Technical standards and guidelines for the diagnosis of biotinidase deficiency.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 20539236.
- Also identified by DOI 10.1097/GIM.0b013e3181e4cc0f.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Biotinidase deficiency is an autosomal recessively inherited disorder of biotin recycling that is associated with neurologic and cutaneous consequences if untreated. Fortunately, the clinical features of the disorder can be ameliorated or prevented by administering pharmacological doses of the vitamin biotin. Newborn screening and confirmatory diagnosis of biotinidase deficiency encompasses both enzymatic and molecular testing approaches. These guidelines were developed to define and standardize laboratory procedures for enzymatic biotinidase testing, to delineate situations for which follow-up molecular testing is warranted, and to characterize variables that can influence test performance and interpretation of results.
Medical subject headings
- Biotinidase
- Biotinidase Deficiency
- Mutation
- Neonatal Screening